Definition
Florida SB 844 is a 2026 Florida law that changes the content of the state’s required controlled-substance prescribing continuing education course by adding instruction on treating pain in patients with sickle cell disease, effective July 1, 2026. It does not create a separate new CE hour; it changes what must be covered inside the existing required course for practitioners who must complete it. Florida Senate bill summary Florida Statutes 456.0301
In practical terms, the buyer question is not “Do I owe another Florida mandate?” but “Does my Florida controlled-substance course now include sickle cell disease pain management content?” That distinction matters because Florida licensees often get tripped up by mandate changes that alter course content rather than total CE volume. Florida Senate bill text
Why this matters for Florida prescribers
The law targets the standard two-hour controlled-substance prescribing course required for certain Florida practitioners who are registered with the U.S. Drug Enforcement Administration and authorized to prescribe controlled substances. Starting July 1, 2026, that course must include information on pain treatment for patients with sickle cell disease. Florida Board of Medicine Florida Board of Osteopathic Medicine
The important nuance is scope. SB 844 is a content amendment to an existing prescribing-education requirement under section 456.0301, not a standalone sickle cell CE requirement that all Florida clinicians must separately track. For renewal planning, what changes first is course selection: older controlled-substance courses may no longer be the right fit if they have not been updated for the July 1, 2026 standard. Florida Senate staff analysis
Who this affects
SB 844 applies through Florida’s existing controlled-substance prescribing CE framework, which is tied to practitioners who are DEA-registered and authorized to prescribe controlled substances under the relevant Florida licensing rules and statutes. The exact renewal mechanics still depend on profession-specific board rules, but the core trigger is not “all healthcare professionals”; it is the controlled-substance prescriber requirement. Florida Statutes 456.0301 Florida Department of Health Take Control
-
Florida physicians with DEA registration are within the existing two-hour prescribing-course requirement. Florida Board of Medicine
-
Florida osteopathic physicians with DEA registration are also required to complete a board-approved two-hour prescribing course. Florida Board of Osteopathic Medicine
-
Florida dentists complete a two-hour safe and effective prescribing course at renewal under board requirements. Florida Board of Dentistry
-
Other professions may intersect with the requirement through their own board rules, so the right check is always the profession’s renewal page plus whether the licensee is actually subject to the controlled-substance prescribing mandate. Florida Department of Health Take Control
What changed on July 1, 2026
Before SB 844, Florida already required a board-approved controlled-substance prescribing course for covered prescribers. After SB 844, the course must also address treatment of pain for patients with sickle cell disease. The law took effect on July 1, 2026. Florida Senate bill summary
| Question | Before SB 844 | After July 1, 2026 |
|---|---|---|
| Is there a Florida controlled-substance prescribing CE requirement? | Yes | Yes |
| Is sickle cell disease pain treatment part of that course? | Not specifically required by this law | Yes, required course content |
| Does the law add a separate extra CE hour? | No | No |
| Effective date | Prior rule structure | July 1, 2026 |
Table basis: Florida Senate bill text
Usage examples
Example 1: Florida physician renewing after July 1, 2026
A Florida MD with DEA registration does not need a separate “sickle cell CE” certificate. They need a controlled-substance prescribing course that has been updated to include sickle cell disease pain-management content. Florida Board of Medicine
Example 2: Florida dentist choosing a renewal course
A dentist comparing CE options should verify that the prescribing course reflects the post–July 1, 2026 content standard, rather than assuming any older two-hour opioid or prescribing module still fits the requirement unchanged. Florida Board of Dentistry Florida Senate bill summary
Example 3: Buyer evaluating Renew Now CE
A Florida APRN or other prescriber looking for a course that tracks the updated rule would want to confirm that the course explicitly states it was updated for SB 844 and includes sickle cell pain-treatment content. Renew Now CE’s Florida controlled-substance prescribing course does exactly that on its course page. Renew Now CE course page
Common misconceptions
“SB 844 creates a brand-new Florida CE requirement.”
Not exactly. It changes the required content inside an existing controlled-substance prescribing course. For most buyers, that means the compliance task is course validation, not adding another item to the renewal checklist. Florida Senate staff analysis
“Every Florida healthcare licensee has to take this.”
No. The underlying requirement is tied to practitioners who fall under Florida’s controlled-substance prescribing CE rules, generally those registered with the DEA and authorized to prescribe controlled substances. Florida Statutes 456.0301
“I need a separate sickle cell certificate.”
The law does not require a separate standalone certificate for sickle cell disease pain management. What matters is that the required prescribing course includes that content. Florida Senate bill text
How this shows up in Renew Now CE’s catalog
Renew Now CE offers a Florida controlled-substance prescribing course that states it was updated for SB 844 and now includes the sickle cell disease pain-management requirement. For buyers, the practical advantage is straightforward: you can validate the mandate change on the course page itself instead of inferring compliance from an older generic opioid-prescribing title. Renew Now CE course page
If you are trying to verify whether a specific course fits your renewal obligation, the more reliable workflow is to match the course language to the board requirement and effective date, then confirm whether your profession is actually subject to the prescribing-course mandate. Renew Now CE also has a related guide on how to verify whether a CE course fits your license renewal requirement.
Related terms
-
Controlled-substance prescribing CE: Florida’s required continuing education course for certain DEA-registered practitioners authorized to prescribe controlled substances. Florida Statutes 456.0301
-
DEA registration: Federal registration with the U.S. Drug Enforcement Administration that is part of the trigger for Florida’s prescribing-course requirement. Florida Statutes 456.0301
-
Sickle cell disease pain management: The clinical topic SB 844 adds to the required Florida prescribing course content beginning July 1, 2026. Florida Senate bill summary
-
Board-approved course: A course accepted by the relevant Florida licensing board for satisfying a mandatory renewal requirement. Florida Board of Medicine
Frequently asked questions
Do Florida APRNs and nurse practitioners need a separate sickle cell CE course under SB 844?
No—Florida APRNs and nurse practitioners who are subject to the controlled-substance prescribing requirement need a compliant prescribing course, not a separate standalone sickle cell certificate. As of July 1, 2026, the required sickle cell disease pain-treatment content must be included inside the existing controlled-substance prescribing CE course. The practical check is whether the course page explicitly reflects the post–July 1, 2026 SB 844 content standard, not whether it has a separate sickle cell title. Florida Senate bill text Renew Now CE course page
If I already completed a Florida controlled-substance course before July 1, 2026, do I need to retake it because of SB 844?
Not automatically—the key question is whether your renewal obligation requires a course that must meet the post–July 1, 2026 content standard. SB 844 changed required course content effective July 1, 2026, but it did not create an extra CE hour or a separate one-time training. For a renewal after that date, buyers should verify that the course they plan to use aligns with the updated requirement rather than assuming an older opioid or prescribing module still fits unchanged. Florida Senate bill summary Florida Senate staff analysis of SB 844
How can I tell whether a Florida prescribing CE course is actually updated for SB 844?
The safest way is to look for course language that specifically says the course includes sickle cell disease pain-management content and was updated for the July 1, 2026 Florida requirement. This matters because SB 844 changed what the controlled-substance course must cover, not the course title or total hours. A generic older prescribing course may look similar at a glance, so buyers trying to avoid research-heavy renewal mistakes should validate the effective date and required content on the course page itself. Florida Senate bill summary How to verify whether a CE course fits your license renewal requirement
Is Florida SB 844 relevant if I do not have DEA registration or do not prescribe controlled substances?
Usually no—SB 844 matters through Florida’s existing controlled-substance prescribing CE framework, which is tied to practitioners who are DEA-registered and authorized to prescribe controlled substances. It is not a universal Florida CE mandate for every healthcare licensee. If you are unsure, the right workflow is to check your profession’s Florida renewal page and confirm whether you are personally subject to the prescribing-course requirement before buying a course. Florida Statutes section 456.0301 Florida Department of Health Take Control overview
Can I get Florida controlled-substance CE with the updated sickle cell content without a subscription?
Yes—Renew Now CE offers a Florida controlled-substance prescribing course as a one-time purchase rather than a subscription, and the course page states that it was updated for SB 844 to include the sickle cell disease pain-management requirement. For individual buyers who want to purchase exactly the mandate they owe instead of joining an annual membership, that makes the main evaluation question simple: confirm the course matches your profession’s board requirement and the July 1, 2026 content change. Renew Now CE course page